
Current Market Outlook
Nothing much changed with the market’s evidence last week: The trends of the major indexes and most leading stocks remain strongly up, and there’s been very little in the way of intermediate-term abnormal selling action out there. On the other hand, many indexes have yet to hit new post-virus highs, fewer stocks are hitting new highs and the leading big-cap indexes are extended to the upside. As always, we put most of our emphasis on the primary evidence, which is why we remain mostly bullish; in fact, we’re nudging our Market Monitor up to a level 7 this week. But, while we still favor holding your strong, resilient performers, we also think it’s best to be choosy on the buy side, looking for names that have shown some recent power on earnings or have been running for a few months but have dipped to support.
Happily, this week’s list features many of names that have one of those two chart characteristics. Our Top Pick is
Redfin (RDFN), which has been mostly a bust since coming public two years ago but showed overwhelming buying after earnings last week. As with most names, try to enter on some weakness.
| Stock Name | Price | Buy Range | Loss Limit |
|---|
| Acceleron Pharma (XLRN) | 75.11 | 88-92 | 78-80 |
| Alteryx (AYX) | 132.78 | 149-155 | 135-138 |
| Amazon.com (AMZN) | 2.00 | 2100-2150 | 1940-1970 |
| Appian (APPN) | 46.48 | 56-59 | 50-52 |
| Envestnet (ENV) | 77.12 | 81-84 | 74.5-76 |
| Invitae (NVTA) | 32.06 | 25-27 | 21.5-23 |
| iRhythm Technologies (IRTC) | 51.15 | 87-90 | 78-80 |
| Redfin (RDFN) | 40.40 | 28.5-30.5 | 24.5-25.5 |
| Sunrun (RUN) | 38.40 | 19.8-20.8 | 17.8-18.4 |
| Survey Monkey (SVMK) | 19.97 | 20.7-21.4 | 18.3-18.7 |